Julien Kirchgesner

Associate Professor

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Glen Doherty

UCD Full Clinical Professor

Dublin City University

IRELAND

View details

Grégory DA COSTA

Institut National de Recherche pour l'Agriculture l'Alimentation et l'Environnement

FRANCE

View details

nathalie ROLHION

INSERM

FRANCE

View details

Javier Pérez Gisbert

Tenure Professor

Universidad Autónoma de Madrid

SPAIN

View details

Jérémie H. Lefèvre

FRANCE

View details

Flavio Caprioli

Associate professor

Università degli Studi di Torino

ITALY

View details

Florian N Loch

Charité - Universitätsmedizin Berlin

GERMANY

View details

Mathieu Uzzan

FRANCE

View details

Sebastian Schneeweiss

Harvard University

UNITED STATES

View details

Sebastian Schölch

Head

German Cancer Research Center (DKFZ)

GERMANY

View details

Daniel Ward

Aalborg University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Julien Kirchgesner

Research Interests

Explore related searches

Contact this professor

Articles (19)

Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study

Strengthening Real‐World Evidence on Question Not Answered by Randomized Trials: A Trial Calibration Approach

Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European Consensus

A methodological review of the high-dimensional propensity score in comparative-effectiveness and safety-of-interventions research finds incomplete reporting relative to algorithm development and robustness

Inflammatory bowel diseases and eosinophilic oesophagitis: Two overlapping disorders?

Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases

Editorial: Pip pip to PIPs (post‐ inflammatory polyps) as a neoplasia risk factor in IBD? Authors' reply

Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies

Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases

Letter: histologic disease activity and colorectal neoplasia risk—authors' reply

Perianal fistulizing Crohn's disease and overall risk of cancer: No red flag

Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post‐inflammatory polyps

Risk of Recurrent Acute Arterial Events Associated With Thiopurines and Anti-Tumor Necrosis Factor in Inflammatory Bowel Diseases

Inflammatory bowel diseases and eosinophilic oesophagitis: Two overlapping disorders?

Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID

Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies

Risk of acute arterial events associated with treatment of inflammatory bowel diseases: a nationwide Danish cohort study

C-reactive protein values after surgery for inflammatory bowel disease: is it still a good marker for intra-abdominal complication? A retrospective cohort study of 347 procedures : CRP after inflammatory bowel disease surgery.

Prognostic value of primary tumor sidedness in patients with non-metastatic IBD related CRC - Is it the exception to the rule?

Collaborators (11)

Glen Doherty

Grégory DA COSTA

nathalie ROLHION

Javier Pérez Gisbert

Jérémie H. Lefèvre

Flavio Caprioli

Florian N Loch

Mathieu Uzzan

Sebastian Schneeweiss

Sebastian Schölch

Daniel Ward

Make your next move.